Suppr超能文献

在各种青霉素治疗临床失败后分离出的产β-内酰胺酶细菌。

beta-Lactamase-producing bacteria recovered after clinical failures with various penicillin therapy.

作者信息

Brook I

出版信息

Arch Otolaryngol. 1984 Apr;110(4):228-31. doi: 10.1001/archotol.1984.00800300020004.

Abstract

The presence of beta-lactamase-producing bacteria in clinical specimens was investigated in 185 children with orofacial or respiratory tract infections. All of these patients failed to respond to antimicrobial therapy, including penicillins, that was administered to 148 (80%) of them. beta-Lactamase-producing aerobic and anaerobic bacteria were detected in 75 (40.5%) of the 185 children. The beta-lactamase-producing strains included all 11 strains of the Bacteroides fragilis group, 30 (45.4%) of the 66 strains of Bacteroides melaninogenicus group, five (41.7%) of the 12 strains of Bacteroides oralis, and 41 (97.6%) of 42 strains of Staphylococcus aureus. All beta-lactamase-producing Bacteroides strains were resistant to penicillin as compared with the non-beta-lactamase-producing strains. Clinical cure was achieved after surgical drainage and a change in antimicrobial therapy in most of the patients. In treatment of orofacial and respiratory tract infections, the clinician should consider the presence of beta-lactamase-producing Bacteroides sp and S aureus as a possible cause of clinical failure with various penicillin therapies.

摘要

对185例患有口面部或呼吸道感染的儿童的临床标本中产β-内酰胺酶细菌的存在情况进行了调查。所有这些患者对抗菌治疗均无反应,其中148例(80%)接受了包括青霉素在内的抗菌治疗。在185名儿童中,有75名(40.5%)检测出产β-内酰胺酶的需氧菌和厌氧菌。产β-内酰胺酶的菌株包括脆弱拟杆菌群的所有11株菌株、产黑色素拟杆菌群66株菌株中的30株(45.4%)、口腔拟杆菌12株菌株中的5株(41.7%)以及金黄色葡萄球菌42株菌株中的41株(97.6%)。与不产β-内酰胺酶的菌株相比,所有产β-内酰胺酶的拟杆菌菌株均对青霉素耐药。大多数患者在手术引流和抗菌治疗改变后实现了临床治愈。在治疗口面部和呼吸道感染时,临床医生应考虑产β-内酰胺酶的拟杆菌属和金黄色葡萄球菌的存在可能是各种青霉素治疗临床失败的原因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验